Seminars in Radiation Oncology
Volume 16, Issue 2 , Pages 120-130, April 2006

Solitary Metastases: Illusion Versus Reality

  • Philip Rubin, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Philip Rubin, MD, Department of Radiation Oncology, James P. Wilmot Cancer Center at the University of Rochester School of Medicine and Dentistry, 601 Elmwood Ave. Box 647, Rochester, NY 14642.
  • ,
  • Ralph Brasacchio, MD
  • ,
  • Alan Katz, MD, MPH

Department of Radiation Oncology, James P. Wilmot Cancer Center at the University of Rochester School of Medicine and Dentistry, Rochester, NY

“Suddenly a solitary horseman appeared on the horizon, then another, then anotherin a few moments a whole crowd of horsemen swooped down upon him.”—Leacock

The illusion of solitary metastases is counterintuitive but has generated a sizable literature on the subject. The reality is that there are more metastatic deaths each year than the total number of true long-term survivors of solitary metastases combining all organ sites in the literature of the past century up to the present time. The largest number of solitary metastases survivors had metastases primarily in the lung and/or liver. With innovations in molecular imaging and advances in molecular oncology, the stage is set to detect truly solitary metastases early. Then, aggressive treatment by surgical excision, stereotactic body radiosurgery, targeted chemotherapy, or immunotherapy could eradicate the lesion. A comprehensive review of solitary metastases in a large variety of anatomic sites is presented. A broader staging system is recommended to encompass a solitary metastasis (M1) and oligometastases (M2) as distinct from multiple metastases (M3).

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1053-4296(05)00102-5

doi:10.1016/j.semradonc.2005.12.007

Seminars in Radiation Oncology
Volume 16, Issue 2 , Pages 120-130, April 2006